Edition:
United Kingdom

Sienna Biopharmaceuticals Inc (SNNA.OQ)

SNNA.OQ on NASDAQ Stock Exchange Global Select Market

15.54USD
7:38pm GMT
Change (% chg)

$1.02 (+7.02%)
Prev Close
$14.52
Open
$14.67
Day's High
$16.15
Day's Low
$14.67
Volume
23,218
Avg. Vol
19,287
52-wk High
$28.95
52-wk Low
$13.37

Chart for

About

Sienna Biopharmaceuticals, Inc. is a United States-based medical dermatology and aesthetics company. The Company focuses on developing targeted therapies to treat inflammatory skin conditions and aesthetic concerns that impact the health and appearance of patients. Its research and clinical-stage candidates include programs,... (more)

Overall

Beta: --
Market Cap(Mil.): $481.46
Shares Outstanding(Mil.): 20.53
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 83.93 16.60
EPS (TTM): -- -- --
ROI: -- 1.66 10.66
ROE: -- 2.58 14.30

BRIEF-Sienna Biopharma Announces First Patient Dosed In First-In-Human Trial Of Topical SNA-125

* SIENNA BIOPHARMACEUTICALS ANNOUNCES FIRST PATIENT DOSED IN FIRST-IN-HUMAN TRIAL OF TOPICAL SNA-125

14 Feb 2018

BRIEF-Sienna Biopharmaceuticals posts qtrly loss per share $1.12‍​

* Sienna Biopharmaceuticals reports third quarter 2017 financial results

09 Nov 2017

BRIEF-Sienna Biopharmaceuticals announces first patient dosed in phase 2B trial of topical SNA-120

* Sienna Biopharmaceuticals announces first patient dosed in phase 2B trial of topical SNA-120

24 Oct 2017

BRIEF-Sienna Biopharmaceuticals reports Q2 loss of $6.50/shr

* Sienna Biopharmaceuticals reports second quarter 2017 financial results

07 Sep 2017

Earnings vs. Estimates